New target identification has been impacted by what has been termed the "genome rush" 1 ... drug discovery in the next 2–5 years, bringing the total number at that point to about 80%. Metabolism ...

and phase-II (conjugating) enzymes have been extensively studied. This review introduces the concept of pharmacogenetics in the context of drug-metabolizing enzymes and highlights the ...